A substantially higher incidence is observed in those exposed to mAb or high-dose corticosteroids under contemporary treatment protocols, particularly among individuals with persistent CD4+ lymphopenia–a marker of impaired immune reconstitution that warrants prolonged monitoring (14, 15). This evidence concerns the gene CD4 and lymphopenia.